Chinese team research published in "Nature" creates a new model for adaptive therapy of nasopharyngeal cancer.

Reporters learned from the Zhongshan University Cancer Prevention and Treatment Center on the 12th that the team of Sun Ying and Lv Jiawei at the center has proposed and verified for the first time a new strategy for dynamic risk adaptive therapy for nasopharyngeal cancer. This strategy upgrades traditional "one-size-fits-all" treatment to precise individualized diagnosis and treatment, thereby extending the survival time of patients.